Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Efficacy, safety, and lot-to-lot immunogenicity of an ina... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial
0
Authors
Raches Ella
97 more
Raches Ella
•
Mansi Jain
95 more
•
Randeep Guleria
Published
November 11, 2021
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to comment
Add a comment...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
The Lancet
Topics
Medicine
Immunology
Pathology
Internal Medicine
Infectious Diseases
Show all topics
DOI
10.1016/s0140-6736(21)02000-6
License
other-oa
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
The Lancet
Topics
Medicine
Immunology
Pathology
Internal Medicine
Infectious Diseases
Show all topics
DOI
10.1016/s0140-6736(21)02000-6
License
other-oa
